Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

about

Human Herpesvirus 8 and Lymphoproliferative Disorders

P2860

Q58701113-5AAD5816-8642-4860-89EA-72CAB4CA8268

P2860

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

Item

http://www.wikidata.org/entity/Q42910824

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@en

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@nl

type

Item

label

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@en

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@nl

prefLabel

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@en

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@nl

P1476

Antineoplastic effects of lipo ...... in primary effusion lymphoma.

@en

P2093

Adriana Mattiolo

http://www.w3.org/2001/XMLSchema#string

Alberto Amadori

http://www.w3.org/2001/XMLSchema#string

Barbara Ruozi

http://www.w3.org/2001/XMLSchema#string

Chiara Quadrelli

http://www.w3.org/2001/XMLSchema#string

Daniela Vallerini

http://www.w3.org/2001/XMLSchema#string

Fabio Forghieri

http://www.w3.org/2001/XMLSchema#string

Flavio Forni

http://www.w3.org/2001/XMLSchema#string

Giorgia Corradini

http://www.w3.org/2001/XMLSchema#string

Giovanni Riva

http://www.w3.org/2001/XMLSchema#string

Ivana Lagreca

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Immunoliposomal systems targeting primary effusion lymphoma: in vitro study.

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.

KSHV/HHV8-associated lymphomas.

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile.

RNAi therapeutics: a potential new class of pharmaceutical drugs.

Knocking down barriers: advances in siRNA delivery.

Liposomal siRNA nanocarriers for cancer therapy.

Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes.

Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.

P304

e467-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2015.126854

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280389010

http://www.w3.org/2001/XMLSchema#string

P698

26206802

http://www.w3.org/2001/XMLSchema#string

P932

4825307

http://www.w3.org/2001/XMLSchema#string

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

about

P2860

P2860

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932